“Efficacy and Safety of Apremilast in Patients With Genital Psoriasis: Results From the Phase 3, Randomized, Placebo-Controlled, Double-blind DISCREET Study”, J of Skin, vol. 7, no. 2, p. s110, Mar. 2023, doi: 10.25251/skin.7.supp.110.